Brought to you by:
Interim results of covered stent-graft hint at ‘new avenue’ in dialysis access treatment
The interim results of a first-in-human trial of a sirolimus-eluting covered stent graft—Solaris DE (Solaris Endovascular)—for the treatment of dialysis access dysfunction demonstrate the promise of the device in treating vascular access outflow stenosis, an investigator in the trial has…
PERT, AI and the rise of thrombectomy devices: ‘PERT leads to more advanced thrombectomy removal therapies, lower hospital stays’
The increasing sophistication of the device space for the treatment of pulmonary embolism (PE) aligned with advances in the deployment of pulmonary embolism response teams (PERTs) are among factors leading to notable improvements in care, according to leading vascular surgeon…
CREST-2: Landmark trial finds benefit from carotid stenting
The National Institutes of Health (NIH)-funded CREST-2 study has found that, for people with high-grade asymptomatic carotid artery stenosis who have not experienced recent stroke symptoms, a carotid artery stenting (CAS) procedure—combined with intensive medical therapy—significantly lowered stroke and death…
‘Historical’ CREST-2 data show reduced stroke risk with carotid stenting versus medical therapy alone
The international CREST-2 study has found that, for people with severe carotid artery narrowing who have not experienced recent stroke symptoms, a minimally invasive carotid artery stenting (CAS) procedure—combined with intensive medical therapy—significantly lowered stroke risk compared with medical therapy…
Atherectomy in PAD: Meta-analysis of ‘extensive’ published literature supports use in ‘appropriately selected’ patients
A systematic review and meta-analysis of more than 300 original investigations on atherectomy in peripheral arterial disease (PAD) highlights “overall favorable” clinical outcomes. This and other findings from what researchers say is the first investigation to provide a “comprehensive” overview…